D-0543-2026 Class II Ongoing
FDA drug recall D-0543-2026 was initiated by ANI Pharmaceuticals, Inc. on May 12, 2026 and is designated Class II. Reason for recall: Defective Container; packets were found to be either empty or partially full. The recall status is ongoing. Affected quantity: 3964 Cartons.
Recall details
- Product Type
- Drugs
- Report Date
- May 27, 2026
- Initiation Date
- May 12, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3964 Cartons
Product description
Estradiol Gel, 0.1%, 0.25 mg, 0.25 g per packet, 30 packets per carton, Rx only, Distributed by: ANI Pharmaceuticals, Inc., Baudette, MN 56623. NDC 70954-531-20
Reason for recall
Defective Container; packets were found to be either empty or partially full.
Distribution pattern
Nationwide in the USA
Code information
Lot M251109, exp Nov 2027
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0543-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026